The cytokine interferon-γ (IFN-γ) is approved as a drug to treat chronic granulomatous disease (CGD) and osteopetrosis and is also used in hyperimmunoglobulin E syndromes. Patients with CGD have defec
Treatment with IFNγ results in alteration of miRNA expression in young adult mouse colonocyte (YAMC) cells. We used microarrays to examine the effect of IFNγ on miRNA expression in intestinal epitheli
